This study investigates pancreatic cancer. It focuses on creating a registry to understand treatment options and outcomes for a specific investigational treatment used in surgical interventions.
This study evaluates the use of an investigational treatment for pancreatic cancer, examining its safety and effectiveness. The purpose of this study is to provide data on complications and other outcomes.
- Who can participate: Adults over 18 with pancreatic cancer eligible for soft tissue ablation can participate. Those with cardiac pacemakers or recent myocardial infarction are excluded.
- Study details: Participants will undergo investigational treatment for pancreatic cancer. Some may receive a placebo, which is an inactive substance that looks like the investigational treatment but contains no medicine.
How understandable was the trial content above?
Hard to understand
Easy to understand